HomeCompareELKEF vs MRK

ELKEF vs MRK: Dividend Comparison 2026

ELKEF yields 0.97% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $36.9K in total portfolio value
10 years
ELKEF
ELKEF
● Live price
0.97%
Share price
$3.10
Annual div
$0.03
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$19.8K
Annual income
$0.10
Full ELKEF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — ELKEF vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodELKEFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ELKEF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ELKEF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ELKEF
Annual income on $10K today (after 15% tax)
$82.26/yr
After 10yr DRIP, annual income (after tax)
$0.09/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $8,328.33/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ELKEF + MRK for your $10,000?

ELKEF: 50%MRK: 50%
100% MRK50/50100% ELKEF
Portfolio after 10yr
$38.3K
Annual income
$4,899.12/yr
Blended yield
12.79%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

ELKEF
Analyst Ratings
1
Hold
Consensus: Hold
Altman Z
2.1
Piotroski
4/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ELKEF buys
0
MRK buys
0
No recent congressional trades found for ELKEF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricELKEFMRK
Forward yield0.97%2.76%
Annual dividend / share$0.03$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%32.7%
Portfolio after 10y$19.8K$56.8K
Annual income after 10y$0.10$9,798.13
Total dividends collected$97.00$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: ELKEF vs MRK ($10,000, DRIP)

YearELKEF PortfolioELKEF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$10,748$48.39$11,206$366.19$458.00MRK
2$11,525$24.30$12,650$502.35$1.1KMRK
3$12,344$12.18$14,407$694.19$2.1KMRK
4$13,214$6.09$16,585$967.82$3.4KMRK
5$14,142$3.05$19,342$1,363.89$5.2KMRK
6$15,134$1.52$22,913$1,947.19$7.8KMRK
7$16,194$0.76$27,662$2,823.89$11.5KMRK
8$17,328$0.38$34,159$4,173.35$16.8KMRK
9$18,541$0.19$43,337$6,308.80$24.8KMRK
10$19,839$0.10$56,776$9,798.13$36.9KMRK

ELKEF vs MRK: Complete Analysis 2026

ELKEFStock

Elkem ASA manufactures and sells metals and materials in Norway, the United Kingdom, Germany, France, Italy, Poland, Spain, the Netherlands, and othe European countries. It operates through three segments: Silicones, Silicon Products, and Carbon Solutions. The Silicones segment produces and sells various silicone-based products across various sub-sectors, including release coatings, engineering elastomers, healthcare products, specialty fluids, emulsions, and resins. The Silicon Products segment produces various grades of metallurgical silicon, ferrosilicon, foundry alloys, and micro silica for use in various end applications. The Carbon Solutions segment produces carbon electrode materials, lining materials, and specialty carbon products for metallurgical processes to produce various metals. Elkem ASA also engages in the generation and sale of hydroelectric power, as well as supplies heat in the form of steam and hot water. The company was incorporated in 1904 and is headquartered in Oslo, Norway. Elkem ASA is a subsidiary of Bluestar Elkem International Co., Ltd. S.A.

Full ELKEF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this ELKEF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ELKEF vs SCHDELKEF vs JEPIELKEF vs OELKEF vs KOELKEF vs MAINELKEF vs JNJELKEF vs ABBVELKEF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.